{"certainAgreement":{"otherDetails":"There IS an agreement between the Principal Investigator and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.","piSponsorEmployee":false,"restrictionType":"OTHER","restrictiveAgreement":true},"pointOfContact":{"email":"clinicaltrials@alexion.com","organization":"Alexion Pharmaceuticals, Inc.","phone":"1-855-752-2356","title":"Alexion Pharmaceuticals, Inc."}}